Latest Ratings for VNDA
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | Jefferies | Downgrades | Buy | Hold |
| May 2021 | B of A Securities | Initiates Coverage On | Buy | |
| Jan 2021 | Citigroup | Downgrades | Buy | Neutral |
A Glimpse Into The Expert Outlook On Vanda Pharma Through 4 Analysts
